GeneOne Life Science Inc Net Asset Quality Index
GeneOne Life Science Inc net asset quality index. GeneOne Life Science Inc (011000) has a Net Asset Quality Index of 39.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩131.29 Billion minus total liabilities of ₩80.13 Billion yields net assets of ₩51.15 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See GeneOne Life Science Inc shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of GeneOne Life Science Inc (2009–2025)
Net asset quality index of GeneOne Life Science Inc from 2009 to 2025. This chart shows how GeneOne Life Science Inc's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of March 2026, the index stands at 39.0%, representing net assets of ₩51.15 Billion against total assets of ₩131.29 Billion KRW. Check 011000 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
GeneOne Life Science Inc Net Asset Quality Index by Year (2009–2025)
GeneOne Life Science Inc net asset quality index by year from 2009 to 2025. The table below presents the year-by-year Net Asset Quality Index for GeneOne Life Science Inc from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 011000 stock market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.3% | ₩40.90 Billion | ₩119.21 Billion | ₩78.31 Billion | ▼ -22.3 pp |
| 2024 | 56.6% | ₩85.61 Billion | ₩151.33 Billion | ₩65.73 Billion | ▼ -17.3 pp |
| 2023 | 73.8% | ₩111.49 Billion | ₩151.01 Billion | ₩39.52 Billion | ▼ -7.6 pp |
| 2022 | 81.4% | ₩181.47 Billion | ₩222.87 Billion | ₩41.40 Billion | ▼ -0.9 pp |
| 2021 | 82.3% | ₩205.45 Billion | ₩249.50 Billion | ₩44.04 Billion | ▲ +10.2 pp |
| 2020 | 72.1% | ₩98.51 Billion | ₩136.57 Billion | ₩38.06 Billion | ▲ +25.1 pp |
| 2019 | 47.0% | ₩24.06 Billion | ₩51.15 Billion | ₩27.09 Billion | ▼ -12.6 pp |
| 2018 | 59.7% | ₩29.41 Billion | ₩49.30 Billion | ₩19.89 Billion | ▼ -20.4 pp |
| 2017 | 80.1% | ₩36.54 Billion | ₩45.63 Billion | ₩9.09 Billion | ▲ +25.5 pp |
| 2016 | 54.6% | ₩35.85 Billion | ₩65.66 Billion | ₩29.81 Billion | ▼ -28.1 pp |
| 2015 | 82.7% | ₩39.44 Billion | ₩47.69 Billion | ₩8.25 Billion | ▼ -2.5 pp |
| 2014 | 85.2% | ₩34.73 Billion | ₩40.77 Billion | ₩6.03 Billion | ▲ +10.7 pp |
| 2013 | 74.5% | ₩23.71 Billion | ₩31.82 Billion | ₩8.11 Billion | ▲ +7.6 pp |
| 2012 | 66.9% | ₩26.74 Billion | ₩39.96 Billion | ₩13.22 Billion | ▼ -16.6 pp |
| 2011 | 83.5% | ₩33.79 Billion | ₩40.46 Billion | ₩6.67 Billion | ▲ +3.5 pp |
| 2010 | 80.0% | ₩32.04 Billion | ₩40.05 Billion | ₩8.02 Billion | ▲ +12.7 pp |
| 2009 | 67.3% | ₩39.74 Billion | ₩59.04 Billion | ₩19.30 Billion | — |